Paragon Wealth Strategies’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,000
Closed -$368K 41
2022
Q1
$368K Hold
5,000
0.1% 38
2021
Q4
$715K Hold
5,000
0.17% 31
2021
Q3
$1.04M Hold
5,000
0.28% 26
2021
Q2
$1.06M Hold
5,000
0.29% 25
2021
Q1
$907K Buy
+5,000
New +$996K 0.28% 25

Other funds holding NVAX

Paragon Wealth Strategies's NVAX Position: Q2 2022 in Review

Paragon Wealth Strategies sold out of Novavax (NVAX) in Q2 2022, closing a stake of 5,000 shares — an estimated $368K sold.

Paragon Wealth Strategies first reported a position in NVAX in Q1 2021 and held it in 5 quarters. The position peaked at $1.06M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Paragon Wealth Strategies reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Paragon Wealth Strategies sold 5,000 Novavax shares in Q2 2022, an estimated $368K.
  • Paragon Wealth Strategies first reported a position in Novavax in Q1 2021 and held it in 5 quarters.
  • Paragon Wealth Strategies's Novavax position peaked at $1.06M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Paragon Wealth Strategies's 13F filing for Q2 2022, filed 11 Jul 2022.